Mirae Asset Global Investments
ANIP icon

Mirae Asset Global Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Mirae Asset Global Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.2K Sell
1,017
-152
-13% -$12.2K ﹤0.01% 1276
2026
Q1 		$89.9K Buy
1,169
+78
+7% +$6.09K ﹤0.01% 1201
2025
Q4 		$86.1K Buy
1,091
+253
+30% +$21.9K ﹤0.01% 1289
2025
Q3 		$76.8K Buy
838
+2
+0.2% +$163 ﹤0.01% 1268
2025
Q2 		$54.5K Buy
836
+114
+16% +$7.42K ﹤0.01% 1243
2025
Q1 		$48.8K Buy
722
+22
+3% +$1.31K ﹤0.01% 1244
2024
Q4 		$38.1K Sell
700
-61
-8% -$3.5K ﹤0.01% 1310
2024
Q3 		$44.7K Buy
761
+135
+22% +$8.24K ﹤0.01% 1321
2024
Q2 		$39.5K Buy
+626
New +$40.6K ﹤0.01% 1287

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Mirae Asset Global Investments's ANIP Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its ANI Pharmaceuticals (ANIP) stake by 13% in Q2 2026, selling an estimated $12.2K and leaving 1,017 shares worth $84.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1276.

Mirae Asset Global Investments first reported a position in ANIP in Q2 2024 and has held it in 9 quarters since. The position peaked at $89.9K in Q1 2026. 105 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Mirae Asset Global Investments held 1,017 shares of ANI Pharmaceuticals worth $84.2K as of Q2 2026.
  • Mirae Asset Global Investments sold 152 ANI Pharmaceuticals shares in Q2 2026, an estimated $12.2K.
  • ANI Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1276 holding.
  • Mirae Asset Global Investments first reported a position in ANI Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's ANI Pharmaceuticals position peaked at $89.9K in Q1 2026.
  • 105 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.